Abstract
Background: Long‐acting muscarinic antagonists/long‐acting beta adrenoreceptor agonists lead to lung deflation and improved microvascular perfusion in hyperinflated chronic obstructive pulmonary disease (COPD), but with an unclear time course. Purpose: To investigate the effect of inhalation of tiotropium/olodaterol (TIO/OLO) on MRI measures of gas uptake and microvascular blood volume after single and multiple doses. Study Type: Prospective, randomized, investigator‐blinded, placebo‐controlled single‐dose crossover study with open‐label multiple‐dose extension. Population: 31 participants with COPD and lung hyperinflation (residual volume > 135% predicted, ≥ 10 pack‐years smoking). Fieldstrength/Sequence: 1.5 T/Interleaved 3D radial gas and dissolved‐phase MRI using multi‐echo FLASH, high‐resolution spectroscopy, chemical shift saturation recovery spectroscopy. Assessment: Ratios of 129 Xe in membrane tissues (M) to gas (M‐Gas), red blood cells (RBC) to gas (RBC‐Gas), RBC to M (RBC‐M) were calculated from dissolved‐phase imaging. Dissolved‐phase apparent transverse relaxation times (T 2 *) from high‐resolution spectra were also calculated, and septal wall thickness and surface‐volume ratio (S/V) were assessed by fitting a model of xenon exchange functions. Parameters were compared for single‐dose (5 μg/5 μg TIO/OLO) versus placebo using saline, and single‐dose versus multiple‐dose (daily 5 μg/5 μg TIO/OLO for 14 days) treatments. Statistical Tests: Linear mixed models with contrasts of estimated marginal means, significance level 0.05. Results: Compared with placebo, single‐dose treatment significantly increased RBC‐Gas and septal thickness but not RBC‐M ( p = 0.06), M‐Gas ( p = 0.16), RBC T 2 * ( p = 0.13), M T 2 * ( p = 0.09) and S/V ( p = 0.47). Multiple‐dose treatment significantly increased RBC‐Gas, M‐Gas and M T 2 * compared with single‐dose treatment, but not RBC‐M ( p = 0.82), RBC T 2 * ( p = 0.48), septal thickness ( p = 0.61), and S/V ( p = 0.49). Data Conclusion: Single‐dose TIO/OLO increased 129 Xe in RBC‐Gas. Multiple‐dose treatment increased M‐Gas and further increased RBC‐Gas compared to single‐dose treatment. Technical Efficacy: Stage 4. Evidence Level: 2.
Funding Information
  • Boehringer Ingelheim
  • Deutsches Zentrum für Lungenforschung

This publication has 27 references indexed in Scilit: